Position in CING
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$164,100
+$102,000 QoQ
Shares Held
30,000
+200.0% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#3
of 8 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CING Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantum Private Wealth, LLC holds $22,191,950 across 8 Biotechnology names. CING ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TSHA |
Taysha Gene Therapies, Inc.
|
812,027 | $5,529,903 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
86,008 | $4,725,279 | |
| 3 | EWTX |
Edgewise Therapeutics, Inc.
|
113,380 | $4,606,629 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
98,365 | $3,837,218 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
6,119 | $2,274,248 | |
| 6 | SLDB |
Solid Biosciences Inc.
|
73,898 | $738,241 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
5,800 | $316,332 | |
| 8 | CING |
Cingulate Inc.
This page
|
30,000 | $164,100 |
All Filings in CING
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,100 | 30,000 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $62,100 | 10,000 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $43,400 | 10,000 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $94,080 | 24,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $40,700 | 10,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $43,000 | 10,000 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||